Next-Generation Sequencing and Proviral DNA: The Future of HIV Drug Resistance Testing? – British Columbia Centre for Excellence

Skip to content

ABOUT
TREATMENT AS
PREVENTION®
HOPE TO HEALTH
RESEARCH & INNOVATION
CENTRE
DRUG TREATMENT
PROGRAMS
RESEARCH

ABOUT
TREATMENT AS
PREVENTION®
HOPE TO HEALTH
RESEARCH & INNOVATION
CENTRE
DRUG TREATMENT
PROGRAMS
RESEARCH

Next-Generation Sequencing and Proviral DNA: The Future of HIV Drug Resistance Testing?

September 23, 2020
Learning Series

Chanson Brumme, PhD
Assistant Director, BC-CfE Research Laboratories
Assistant Professor, UBC Division of Infectious Diseases

Share this video:

PrevPreviousPromoting Wellbeing through the Built Environment at Hope to Health

NextOral Agonist Treatment for Opioid Use DisorderNext

Privacy Notice|Privacy Statement|Personal Information Banks|Website Privacy Policy

© 2025 British Columbia Centre for Excellence
St. Paul's Hospital 608–1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
Tel: 604-806-8477 | Fax: 604-806-9044
General inquiries: info@bccfe.ca
Media inquiries: communications@bccfe.ca

(Please do not use any of these email addresses to send personal information or book an appointment.
To book appointments or contact the H2H clinic, please call 604-416-1517 or fax: 604-564-4893.
Do not send your or your client's personal information via email.)

Scroll to Top

Start typing and press enter to search

Search...